SCHEMBL7664751

SCHEMBL7664751

CCCc1cnc(-c2ccc(F)cc2Oc2ccccc2)cn1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.40
▸ SLC6A4 P31645 2/20 0.40
▸ GRM5 P41594 2/20 0.39
▸ FEN1 P39748 4/20 0.38
▸ ALOX5AP P20292 2/20 0.38
▸ CYP11B1 P15538 2/20 0.37
▸ CYP11B2 P19099 2/20 0.37
▸ SYK P43405 1/20 0.37
▸ BCL2L2 Q92843 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TSPO P30536 1/20 0.35
▸ CHRNA7 P36544 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666782 0.85 NPC1 (0.38) SLC6A4FEN1ALOX5APBCL2L2POLB
SCHEMBL7670839 0.85 CYP11B1 (0.41) CYP11B1CYP11B2SYKBCL2L2POLB
SCHEMBL7664372 0.85 PLAU (0.41) GRM5L3MBTL1
SCHEMBL7672934 0.82 TTR (0.34) SLC6A4FEN1ALOX5APBCL2L2POLB
SCHEMBL7667019 0.82 TRPA1 (0.41) FEN1ALOX5APL3MBTL1
SCHEMBL7664066 0.79 BCL2L2 (0.37) SLC6A4FEN1ALOX5APBCL2L2POLB
SCHEMBL7666933 0.78 CYP11B1 (0.42) GRM5FEN1CYP11B1CYP11B2BCL2L2
SCHEMBL7666947 0.77 FEN1 (0.38) FEN1ALOX5APBCL2L2POLBATM
SCHEMBL7673906 0.72 KEAP1 (0.39) SLC6A4L3MBTL1ALOX15
SCHEMBL7668578 0.72 L3MBTL1 (0.36) FEN1ALOX5APL3MBTL1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback